Soyer, N. Et Al. 2018. Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data. 9th International Eurasian Hematology Oncology Congress (EHOC) , (İstanbul, Turkey).

Soyer, N., Ali, R., Turgut, M., Haznedaroglu, I., Yilmaz, F., Aydogdu, I., ... Pir, A.(2018). Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data . 9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey

Soyer, N. Et Al. "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data," 9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 2018

Soyer, N. Et Al. "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data." 9th International Eurasian Hematology Oncology Congress (EHOC) , İstanbul, Turkey, 2018

Soyer, N. Et Al. (2018) . "Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data." 9th International Eurasian Hematology Oncology Congress (EHOC) , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={N. Soyer Et Al. }, title={Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data}, congress name={9th International Eurasian Hematology Oncology Congress (EHOC)}, city={İstanbul}, country={Turkey}, year={2018}}